Bringing together experts from across disciplines, ESC Cardio-Oncology 2026 will foster collaboration, inspire innovation and help shape the future of cardio-oncology care.
The ESC Cardio-Oncology 2026, the annual conference of the ESC Council of Cardio-Oncology, will take place in Vienna on 19–20 June and bring together leading clinicians, researchers, healthcare professionals and industry representatives working at the forefront of the field.
For the COMPASS project, the event provides an important platform to share knowledge, engage with the wider cardio-oncology community and contribute to discussions shaping the future of cardiovascular health in oncology. Bringing together European and international specialists from cardiology, oncology, haematology, radiotherapy and related disciplines, ESC Cardio-Oncology 2026 will provide a unique forum for exchanging expertise, addressing emerging challenges and exploring innovative approaches to patient care.
As a project dedicated to optimising the cardiovascular health of cancer patients and survivors through a comprehensive, patient-centred approach, COMPASS is closely aligned with many of the themes that will be explored throughout the event. From early cardiotoxicity risk prediction and advanced imaging technologies to AI-driven decision support and long-term survivorship care, the conference reflects several of the priorities currently being addressed within the project.
The COMPASS consortium looks forward to the valuable discussions, scientific exchanges and insights that will emerge from ESC Cardio-Oncology 2026, contributing to ongoing efforts to advance cardiovascular care for cancer patients and survivors across Europe.
Stay tuned for further updates on COMPASS participation at ESC Cardio-Oncology 2026!
The COMPASS project was showcased at MedTech Forum 2026 in Stockholm through a poster presentation, highlighting the project’s multidisciplinary approach to advancing cardio-oncology care in Europe.
Last week, the MedTech Forum once again confirmed its position as one of Europe’s leading conferences for the medical technology sector. Held this year in Stockholm, the event brought together healthcare professionals, industry leaders, innovators and policymakers from across Europe to discuss the future of medical technology, digital health and innovation in healthcare systems.
The COMPASS project was showcased at the forum through the participation of project partners, including GE HealthCare and the Global Heart Hub, fostering exchange and discussion with key stakeholders from across the healthcare and research ecosystem. Through a poster presentation in the exhibition area, the project presented its vision, objectives and multidisciplinary approach to improving cardiovascular care for cancer patients and survivors through innovation, artificial intelligence and integrated care pathways.
Reflecting on the forum, Annamaria Csizmadia, European External Funding CoE Director at GE HealthCare, emphasised the value of collaboration and knowledge exchange across the European healthcare ecosystem: “The real value of these events always lies in the conversations, the exchange of perspectives, and the new opportunities for collaboration”.
Participants and attendees during MedTech Forum 2026Annamaria Csizmadia from GE HealthCare and Marta Bragagnolo from Global Heart Hub
A collaborative space for the future of healthcare
The MedTech Forum 2026 focused on some of the most pressing topics currently shaping the European healthcare landscape, including the evolving EU regulatory landscape and policy priorities, the growing impact of digital health and AI, the improvement of patient access to innovation, and the development of more sustainable and resilient healthcare systems.
For the COMPASS consortium, these discussions closely reflect the project’s own mission: advancing more integrated, personalised and patient-centred approaches to cardio-oncology care through innovation, AI and multidisciplinary collaboration.
Worthy of note was also the strong presence of the Innovative Health Initiative (IHI) throughout the event and its importance in supporting collaborative innovation across Europe. “IHI plays a critical role in fostering cross-sector collaboration between industry, academia, and healthcare stakeholders to drive meaningful, patient-centered innovation”, highlighted Annamaria Csizmadia. She further emphasised the importance of initiatives such as COMPASS “to accelerate the translation of research into real-world clinical impact, solution and to strengthen Europe’s innovation ecosystem”.
As one of the leading industrial partners in the COMPASS consortium, GE HealthCare contributes expertise in medical imaging, artificial intelligence and digital health technologies, supporting the development and validation of innovative imaging approaches, AI-driven tools and integrated digital solutions for cardio-oncology care.
Bringing cardio-oncology innovation to the MedTech community
Participation in MedTech Forum 2026 represented an important opportunity to increase the visibility of COMPASS within the European MedTech and digital health ecosystem, while contributing to ongoing conversations around the future implementation of innovative healthcare solutions.
The forum also provided an opportunity to reflect on how many of the current priorities in healthcare innovation are already converging in practice across European collaborative projects.
For the consortium, events like this are essential not only for disseminating project objectives and innovations, but also for strengthening connections with stakeholders working towards more integrated, accessible and personalised healthcare systems.
